LONDON BROKER RATINGS: Berenberg cuts Whitbread; Citi ups Severn Trent
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 158.00p on 02-02-2026 at 19:40:08 |
|---|---|
| Change | 1.60p 1.02% |
| Buy | 158.20p |
| Sell | 157.80p |
| Last Trade: | Sell 10,044.00 at 157.00p |
| Day's Volume: | 1,841,334 |
| Last Close: | 158.00p |
| Open: | 158.40p |
| ISIN: | GB00B012BV22 |
| Day's Range | 155.00p - 158.40p |
| 52wk Range: | 155.00p - 295.00p |
| Market Capitalisation: | £399.51m |
| VWAP: | 157.21991p |
| Shares in Issue: | 252.85m |
Marshalls (MSLH) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 10,044 | 157.00p | Ordinary |
16:49:06 - 02-Feb-26 |
| Sell* | 20,000 | 158.00p | Ordinary |
16:38:31 - 02-Feb-26 |
| Buy* | 1,948 | 158.00p | Automatic Execution |
16:37:28 - 02-Feb-26 |
| Buy* | 194,294 | 158.00p | Suspected BUY Trade |
16:35:22 - 02-Feb-26 |
| Sell* | 687 | 158.00p | Automatic Execution |
16:28:59 - 02-Feb-26 |
| Sell* | 719 | 158.00p | Automatic Execution |
16:28:59 - 02-Feb-26 |
| Buy* | 402 | 158.00p | Automatic Execution |
16:28:59 - 02-Feb-26 |
| Buy* | 244 | 158.00p | Automatic Execution |
16:28:59 - 02-Feb-26 |
| Buy* | 47 | 158.00p | Automatic Execution |
16:28:46 - 02-Feb-26 |
| Buy* | 7 | 158.00p | Automatic Execution |
16:28:46 - 02-Feb-26 |
Marshalls (MSLH) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 19th Jan 2026 7:01 am | RNS | Trading Statement |
| 19th Jan 2026 7:00 am | RNS | Directorate change |
| 9th Jan 2026 12:40 pm | RNS | Director/PDMR Shareholding |
| 9th Jan 2026 12:38 pm | RNS | Director/PDMR Shareholding |
| 6th Jan 2026 9:36 am | RNS | Notice of Trading Update |
| 9th Dec 2025 3:21 pm | RNS | Director/PDMR Shareholding |
| 27th Nov 2025 7:00 am | RNS | Board changes |
| 12th Nov 2025 7:00 am | RNS | Trading Update |
| 10th Nov 2025 10:30 am | RNS | Director/PDMR Shareholding |
| 10th Nov 2025 10:29 am | RNS | Director/PDMR Shareholding |